SS
HBIO icon

SBI Securities’s Harvard Bioscience HBIO Stock Holding History

SBI Securities’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33K Hold
866
– – ﹤0.01% 2148
2026
Q1 		$4.22K Sell
866
-1
-0.1% -$6 ﹤0.01% 2107
2025
Q4 		$5.8K Hold
867
– – ﹤0.01% 1965
2025
Q3 		$3.8K Hold
867
– – ﹤0.01% 2161
2025
Q2 		$3.85K Hold
867
– – ﹤0.01% 2111
2025
Q1 		$4.91K Buy
867
+586
+209% +$7.5K ﹤0.01% 1909
2024
Q4 		$5.93K Buy
+281
New +$6.45K ﹤0.01% 1861

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's HBIO Position: Q2 2026 in Review

SBI Securities held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 866 shares worth $5.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

SBI Securities first reported a position in HBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.93K in Q4 2024. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • SBI Securities held 866 shares of Harvard Bioscience worth $5.33K as of Q2 2026.
  • SBI Securities left its Harvard Bioscience share count unchanged in Q2 2026.
  • Harvard Bioscience made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2148 holding.
  • SBI Securities first reported a position in Harvard Bioscience in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Harvard Bioscience position peaked at $5.93K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.